Spring 2022 Vol. 12 Issue 01
-
From the Editor-in-Chief
COVID-19 and Cancer in 2022Is it the beginning of the end or the end of the beginning?
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Make the Most of Your AppointmentsTake time to prepare for and manage your doctor visits.
by Hester Hill Schnipper
-
Caregiving With Confidence
A Crash Course in CancerCaregivers can act as teachers and liaisons for their loved ones. Here’s how they can quickly get up to speed on cancer.
by K.J. Bannan
-
Policy Matters
Patient Advocacy Is Driving ChangePatient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.
by Carrie Treadwell, MBA
-
Coping With Chemo Brain
Many cancer patients have problems with memory or thinking that can linger for years after treatment. The cause is a mystery, but new tactics are helping many people cope with its effects.
by Stephen Ornes
-
Cracking the Code of Acute Myeloid Leukemia
Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
by Kendall K. Morgan
-
Medicaid: A Partial Safety Net
Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.
by Sharon Tregaskis
-
Survivor Profile
Grinding Through ItConnor Joe’s grit and determination helped him return to major league baseball after surgery and chemotherapy for testicular cancer that had spread to his lung.
by Marci A. Landsmann
-
Q&A
The Significance of NCI-Designated Cancer CentersCancer center administrator Donald L. “Skip” Trump and journalist Eric Rosenthal discuss the roots of the NCI designation and what it means for patients.
by Marci A. Landsmann
-
Get Involved
Playing the HeroWith the SuperKids activity book, children with cancer cast themselves as the hero and learn important coping skills.
by Eric Fitzsimmons
-
Facts and Stats
HPV Vaccine Prevents CancerSixteen years after the introduction of the HPV vaccine, research sees an effect on cervical cancer rates in young women.
by Eric Fitzsimmons
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff